Inventor profile of:

Shi-Lung Lin

City:

Arcadia, California

Country:

United States

Published Applications:

38

Last publication date:

2025-04-10

Top Assignees for applications by Shi-Lung Lin

The entities that hold a legal rights for patent applications filed by inventor Lin Shi-Lung:

Recent patent applications by Lin Shi-Lung

Shi-Lung Lin from Arcadia, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-10
US20250115932A1
Chemistry; metallurgy

INDUCED CYTOPLASMIC IVT (ICIVT)-LIKE COMPOSITION AND THE RELATED VACCINE MEDICINE DESIGNS THEREOF

#2 | 2025-01-16
US20250019709A1
Chemistry; metallurgy

NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF

#3 | 2024-06-13
US20240189235A1
Human necessities

CATIONIC LIPIDS AND USES THEREOF

#4 | 2024-03-21
US20240093286A1
Chemistry; metallurgy

Novel Replicase Cycling Reaction (RCR) and the Related RdRP-Binding Site Designs Thereof

#5 | 2023-09-21
US20230295627A1
Chemistry; metallurgy

Novel Replicase Cycling Reaction (RCR) and the Related SamRNA Designs Thereof

#6 | 2023-08-03
US20230242958A1
Chemistry; metallurgy

SYNTHETIC RNA FRAGMENT AND ITS USES FOR RNA-DEPENDENT AMPLIFICATION

#7 | 2023-03-30
US20230099592A1
Chemistry; metallurgy

NOVEL REPLICASE CYCLING REACTION (RCR)

#8 | 2022-12-29
US20220411848A1
Chemistry; metallurgy

Novel Replicase Cycling Reaction (RCR)

#9 | 2022-12-15
US20220396798A1
Chemistry; metallurgy

NOVEL MRNA COMPOSITION AND PRODUCTION METHOD FOR USE IN ANTI-VIRAL AND ANTI-CANCER VACCINES

#10 | 2022-12-15
US20220396778A1
Chemistry; metallurgy

Novel RNA Composition and Production Method for Use in iPS Cell Generation

#11 | 2021-04-01
US20210095280A1
Chemistry; metallurgy

Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines

#12 | 2020-10-08
US20200318110A1
Chemistry; metallurgy

A COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER

#13 | 2020-05-28
US20200165607A1
Chemistry; metallurgy

COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER

#14 | 2020-03-05
US20200071700A1
Chemistry; metallurgy

COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS DRUGS FOR TREATING ALZHEIMER'S DISEASES

#15 | 2019-03-21
US20190085335A1
Chemistry; metallurgy

In-vitro induction of adult stem cell expansion and derivation

#16 | 2017-11-30
US20170342418A1
Chemistry; metallurgy

USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION

#17 | 2017-08-03
US20170218362A1
Chemistry; metallurgy

Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases

#18 | 2017-06-22
US20170175118A1
Chemistry; metallurgy

Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer

#19 | 2016-10-06
US20160289682A1
Chemistry; metallurgy

PRODUCTION AND UTILIZATION OF A NOVEL ANTI-CANCER DRUG IN THERAPY

#20 | 2016-09-15
US20160264974A1
Chemistry; metallurgy

Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion

#21 | 2016-08-04
US20160220525A1
Human necessities

Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs

#22 | 2015-07-30
US20150209377A1
Human necessities

Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs

#23 | 2015-05-14
US20150132805A1
Chemistry; metallurgy

Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors

#24 | 2015-04-30
US20150118734A1
Chemistry; metallurgy

Inducible gene expression composition for using eukaryotic pol-2 promoter-driven transcription in prokaryotes and the applications thereof

#25 | 2015-03-05
US20150064771A1
Chemistry; metallurgy

Inducible gene expression composition for using eukaryotic pol-2 promoter-driven transcription in prokaryotes and the applications thereof

#26 | 2014-11-27
US20140350085A1
Human necessities

Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro

#27 | 2014-05-22
US20140141470A1
Chemistry; metallurgy

Production and extraction of MicroRNA precursor as drug for cancer therapy

#28 | 2013-12-05
US20130324590A1
Chemistry; metallurgy

Production and utilization of a novel anti-cancer drug in therapy

#29 | 2013-09-26
US20130252339A1
Chemistry; metallurgy

MICRORNA-INDUCED ES-LIKE CELLS AND USES THEREOF

#30 | 2013-08-15
US20130210120A1
Chemistry; metallurgy

Inducible Gene Expression Composition for Using Eukaryotic Pol-2 Promoter-Driven Transcription in Prokaryotes and the Applications Thereof

#31 | 2011-04-28
US20110098461A1
Chemistry; metallurgy

RNA interference methods using DNA-RNA duplex constructs

#32 | 2010-11-25
US20100298416A1
Chemistry; metallurgy

Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic RNAs

#33 | 2010-09-23
US20100240126A1
Chemistry; metallurgy

Development of universal cancer drugs and vaccines

#34 | 2009-08-13
US20090203141A1
Chemistry; metallurgy

Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents

#35 | 2009-07-02
US20090170204A1
Chemistry; metallurgy

Cosmetic designs and products using intronic RNA

#36 | 2008-11-27
US20080293143A1
Chemistry; metallurgy

Generation of human embryonic stem-like cells using intronic RNA

#37 | 2008-10-02
US20080242627A1
Chemistry; metallurgy

NOVEL RNA INTERFERENCE METHODS USING DNA-RNA DUPLEX CONSTRUCTS

#38 | 2006-10-12
US20060228800A1
Chemistry; metallurgy

Novel Transgenic Methods Using intronic RNA

InventorID:

389964 ⎘